Comparing Venous Thromboembolism Prophylactic Agents After Hip Fracture Surgery: A National Database Study.
Peter Y JooMaxwell ModrakNancy ParkJordan BrandLee E RubinJonathan N GrauerJenna A BernsteinPublished in: Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews (2022)
In evaluating Lovenox, Eliquis, and Coumadin as VTE chemoprophylactic agents after hip fracture surgery in anticoagulant-naïve patients, Lovenox and Eliquis had similar 90-day VTE, whereas patients on Coumadin had greater odds of 90-day VTE. Interestingly, patients on Eliquis had nearly two-fold lower odds of transfusions compared with patients on Lovenox. Although consensus on the optimal VTE prophylactic agent after hip fracture surgery does not exist, Eliquis and Lovenox may be comparable options and seem to be more effective than Coumadin.
Keyphrases
- venous thromboembolism
- hip fracture
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- minimally invasive
- prognostic factors
- coronary artery bypass
- direct oral anticoagulants
- atrial fibrillation
- coronary artery disease
- percutaneous coronary intervention
- patient reported
- quality improvement